Bio-Rad Laboratories, Inc.
BIO
Rankning i aktier
#2168
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Aktiekurs
$352.89
Senast synkroniserad: 2026-10-16
Marknadsvärde
$9.44B
Förändring (1 dag)
-3.34%
Förändring (1 år)
13.83%
Land
US
Handel Bio-Rad Laboratories, Inc. (BIO)
Kategori
Healthcare
EPS för Bio-Rad Laboratories, Inc. (BIO)
EPS per June 2026 TTM: $8.33
Enligt Bio-Rad Laboratories, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $8.33. Vid slutet av 2024 hade bolaget ett EPS på $-65.36, en ökning jämfört med EPS från 2023 som var $-21.82.
EPS-historik för Bio-Rad Laboratories, Inc. från 2000 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $8.33 | -70.11% |
| 2025 | $27.87 | -142.64% |
| 2024 | $-65.36 | 199.54% |
| 2023 | $-21.82 | -82.08% |
| 2022 | $-121.79 | -185.40% |
| 2021 | $142.61 | 11.54% |
| 2020 | $127.86 | 116.97% |
| 2019 | $58.93 | 387.02% |
| 2018 | $12.10 | 193.69% |
| 2017 | $4.12 | 368.18% |
| 2016 | $0.88 | -76.47% |
| 2015 | $3.74 | 21.43% |
| 2014 | $3.08 | 13.24% |
| 2013 | $2.72 | -53.50% |
| 2012 | $5.85 | -8.45% |
| 2011 | $6.39 | -4.63% |
| 2010 | $6.70 | 26.89% |
| 2009 | $5.28 | 60.00% |
| 2008 | $3.30 | -5.17% |
| 2007 | $3.48 | -11.22% |
| 2006 | $3.92 | 25.24% |
| 2005 | $3.13 | 18.11% |
| 2004 | $2.65 | -11.67% |
| 2003 | $3.00 | 11.11% |
| 2002 | $2.70 | 50.84% |
| 2001 | $1.79 | 40.94% |
| 2000 | $1.27 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| $3.11 | -62.67% |
US
|
|
| $3.59 | -56.90% |
IE
|
|
| $9.73 | 16.81% |
US
|
|
| $2.48 | -70.23% |
US
|
|
| - | - |
DE
|
